Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Sutdy to Assess the Effectiveness of Avodart in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice

NCT00316732 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00316732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Sutdy to Assess the Effectiveness of Avodart in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 25, 2004
Completion date
December 19, 2006
Enrollment
173 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia